Stay updated on Pembrolizumab for Recurrent Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows an updated revision tag from v3.5.3 to v3.5.4, indicating a new build or patch. This appears to be maintenance-related and does not alter study content or data presented on the page.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s footer “Revision” has been updated from v3.5.0 to v3.5.3, indicating a platform/version update rather than a change to the study record itself.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no visible changes to the study content.SummaryDifference0.1%

- Check106 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2; no changes to core study information or page layout are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check114 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 was removed from the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Recurrent Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Recurrent Glioblastoma Clinical Trial page.